Dolby Laboratories Inc/ US25659T1079 /
10/4/2024 9:59:52 PM | Chg. +0.10 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
75.71USD | +0.13% | 8,933 Turnover: 673,794.56 |
-Bid Size: - | -Ask Size: - | 7.22 bill.USD | 1.43% | 36.05 |
Fundamentals
FY 2023 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 2.10 USD | 14.13% |
EPS Diluted: | 2.05 USD | 13.26% |
Revenues per Share: | 21.96 USD | 4.86% |
Book Value per Share: | 40.08 USD | 6.60% |
Cash Flow per Share: | 6.20 USD | 16.55% |
Dividend per Share: | 1.08 USD | 8.00% |
Total | in mill. | |
Revenues: | 1,299.74 USD | 3.67% |
Net Income: | 200.66 USD | 9.00% |
Operating Cash Flow: | 367.08 USD | - |
Cash and Cash Equivalents: | 745.36 USD | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 36.05 | 37.74 |
P/S Ratio: | 3.45 | 3.61 |
P/BV ratio: | 1.89 | 1.98 |
P/CF Ratio: | 12.21 | 12.78 |
PEG: | 2.55 | 2.67 |
Earnings Yield: | 2.77% | 2.65% |
Dividend Yield: | 1.43% | 1.36% |
Market Capitalization | ||
Market Capitalization: | 7.22 bill. USD | 4.69 bill. USD |
Free Float Market Cap.: | - USD | - USD |
Market Cap. / Employee: | - USD | - USD |
Shares Outstanding: | 59.68 mill. |
Profitability
Gross Profit Margin: | 88.26% |
EBIT Margin: | 16.60% |
Net Profit Margin: | 15.44% |
Return on Equity: | 8.46% |
Return on Assets: | 6.73% |
Financial Strength
Liquidity I / Cash Ratio: | 1.77% |
Liquidity II / Quick Ratio: | 2.39% |
Liquidity III / Current Ratio: | 3.52% |
Debt / Equity Ratio: | - |
Dynam. Debt / Equity Ratio: | 165.52% |
Efficiency
Employees: | - |
Personal Expenses / Employee: | - USD |
Revenues / Employee: | - USD |
Net Income / Employee: | - USD |
Total Assets / Employee: | - USD |
* Fiscal Year End: | 9/29/2023 |
Accounting Standard: | US GAAP |
Currency: | USD |